Extrait

To investigate the safety and efficacy of long-term administration of aripiprazole by performing extended administration of the treatment administered in the preceding multicenter, double-blind, placebo-controlled, parallel group-comparison trial of aripiprazole in patients with bipolar disorder experiencing a manic or mixed episode (Study 031-06-003, hereafter "Study 003") in a double-blind manner to those patients who complete Study 003 and demonstrate drug efficacy.

Critère d'inclusion

• Bipolar I Disorder

Pays

• China
• Japan
• Korea, Republic of
• Taiwan, Province of China

Liens

• nct
• ictrp